Acxiom Corporation (ACXM) Upgraded at Zacks Investment Research

Acxiom Corporation (NASDAQ:ACXM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Monday, November 6th. The brokerage currently has a $30.00 price objective on the information technology services provider’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 11.90% from the company’s current price.

According to Zacks, “Acxiom reported impressive second-quarter fiscal 2018 results. Both earnings and revenues increased on a year-over-year basis driven by robust performance from the Connectivity segment. With continued solid contributions from LiveRamp, the company is striving to improve the functionality of its products across all channels and devices. IdentityLink has gained significant traction within a short-span of time, which improves company's growth prospects. Moreover, expanding customer base is significantly positive in our view. Nevertheless, we note that the company operates in a competitive landscape that is becoming more complex with low barriers to entry. Notably, the stock has underperformed the industry on a year-to-date basis.”

Other equities analysts also recently issued reports about the stock. BidaskClub raised shares of Acxiom from a “strong sell” rating to a “sell” rating in a report on Wednesday, July 19th. BMO Capital Markets reaffirmed a “buy” rating and issued a $32.00 target price on shares of Acxiom in a research note on Sunday, July 16th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $35.00 target price on shares of Acxiom in a research note on Thursday, November 2nd. Finally, Dougherty & Co reaffirmed a “buy” rating on shares of Acxiom in a research note on Thursday, August 17th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $32.33.

Acxiom (NASDAQ ACXM) opened at $26.81 on Monday. Acxiom has a 12 month low of $21.80 and a 12 month high of $30.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.23 and a current ratio of 2.23. The company has a market cap of $2,134.86, a price-to-earnings ratio of 112.29, a PEG ratio of 5.13 and a beta of 1.28.

Acxiom (NASDAQ:ACXM) last posted its earnings results on Wednesday, November 1st. The information technology services provider reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $225.24 million for the quarter, compared to analyst estimates of $222.05 million. Acxiom had a negative net margin of 1.31% and a positive return on equity of 2.61%. Acxiom’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the business posted $0.18 EPS. research analysts forecast that Acxiom will post 0.35 earnings per share for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in ACXM. ETF Managers Group LLC bought a new position in Acxiom in the second quarter valued at approximately $119,000. Riverhead Capital Management LLC lifted its stake in Acxiom by 73.9% in the second quarter. Riverhead Capital Management LLC now owns 4,694 shares of the information technology services provider’s stock valued at $122,000 after buying an additional 1,994 shares in the last quarter. LS Investment Advisors LLC lifted its stake in Acxiom by 20.5% in the second quarter. LS Investment Advisors LLC now owns 6,172 shares of the information technology services provider’s stock valued at $160,000 after buying an additional 1,050 shares in the last quarter. Shelton Capital Management bought a new position in Acxiom in the second quarter valued at approximately $213,000. Finally, Quantbot Technologies LP lifted its stake in Acxiom by 384.9% in the second quarter. Quantbot Technologies LP now owns 8,825 shares of the information technology services provider’s stock valued at $229,000 after buying an additional 7,005 shares in the last quarter. 95.04% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Acxiom Corporation (ACXM) Upgraded at Zacks Investment Research” was originally reported by BBNS and is owned by of BBNS. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/acxiom-corporation-acxm-rating-increased-to-buy-at-zacks-investment-research/1762639.html.

About Acxiom

Acxiom Corporation (Acxiom) is a technology and enablement services company. The Company operates through three business segments: Marketing Services, Audience Solutions, and Connectivity. The Company’s Marketing Services segment helps clients to unify data at individual level. The Audience Solutions segment helps clients to validate the accuracy of their people-based data, enhance it with additional insight and keep it up to date, enabling clients to reach desired audiences with relevant messages.

Get a free copy of the Zacks research report on Acxiom (ACXM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Acxiom Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acxiom Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan


Leave a Reply

 
© 2006-2017 BBNS.